Application of the international prognostic scoring system-revised in therapy-related myelodysplastic syndromes and oligoblastic acute myeloid leukemia
Leukemia
.
2014 Jan;28(1):185-9.
doi: 10.1038/leu.2013.191.
Epub 2013 Jun 21.
Authors
C Y Ok
1
,
R P Hasserjian
2
,
P S Fox
3
,
F Stingo
3
,
Z Zuo
1
,
K H Young
1
,
K Patel
1
,
L J Medeiros
1
,
G Garcia-Manero
4
,
S A Wang
1
Affiliations
1
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
2
Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
3
Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
4
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
PMID:
23787392
DOI:
10.1038/leu.2013.191
No abstract available
Publication types
Letter
MeSH terms
Female
Humans
Leukemia, Myeloid, Acute / pathology
Leukemia, Myeloid, Acute / therapy*
Male
Middle Aged
Myelodysplastic Syndromes / pathology
Myelodysplastic Syndromes / therapy*
Prognosis